How have RGIN shares performed in 2024?

Regenicin's stock was trading at $0.0001 at the beginning of 2024. Since then, RGIN shares have increased by 4,900.0% and is now trading at $0.0050. View the best growth stocks for 2024 here .

How were Regenicin's earnings last quarter?

Regenicin, Inc. (OTCMKTS:RGIN) released its quarterly earnings results on Wednesday, August, 19th. The company reported $0.00 earnings per share (EPS) for the quarter.

What other stocks do shareholders of Regenicin own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Regenicin investors own include Energous (WATT) , Vital Therapies (VTL) , Xerox (XRX) , Allergan (AGN) , Leafbuyer Technologies (LBUY) , (ZINCQ) (ZINCQ) , Ambarella (AMBA) and Alstom (ALO) .

How do I buy shares of Regenicin?

Shares of RGIN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:RGIN

Regenicin (RGIN) Stock Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Free RGIN Stock Alerts

$0.0050

0.00 (0.00%)

(As of 04/19/2024 ET)

Compare

Today's Range: $0.0050
▼
$0.0050
50-Day Range: N/A
52-Week Range: $0.0001
▼
$0.0050

Volume: N/A
Average Volume: 9,778 shs
Market Capitalization: $828,850.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials SEC Filings

Get Regenicin alerts:

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About Regenicin Stock (OTCMKTS:RGIN)

Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.

RGIN Stock Price History

30 days | 90 days | 365 days | Advanced Chart

RGIN Stock News Headlines

January 20, 2024 | foxnews.com

John Kerry praises Biden for preventing 'uncontrolled war in many regions'

December 9, 2023 | thestreet.com

History of Walmart: Timeline and Facts

April 20, 2024 | Weiss Ratings (Ad)

The only accurate crypto trading system I know …

Juan Villaverde is no ordinary crypto trader. His proprietary timing algorithm has led him to rack up a series of gains of 477%, 333% and 153% on Bitcoin … It pointed the way to Cardano, at just 4 cents …Helping investors make 29 times their money.

August 22, 2023 | foxnews.com

Heavy rains trigger floods and landslides in India's Himalayan region, leaving at least 48 dead

June 13, 2023 | bbc.com

Ukraine army attacks Russian forces in southern Zaporizhzhia region

June 5, 2023 | fortune.com

Regions Financial

April 21, 2023 | reuters.com

Russia's Promsvyazbank opening more branches in annexed regions of Ukraine

April 11, 2023 | bbc.co.uk

Tundra regions of the world

April 20, 2024 | Weiss Ratings (Ad)

The only accurate crypto trading system I know …

March 28, 2023 | health.usnews.com

Regions Hospital

March 18, 2023 | news.yahoo.com

Drought risk to England regions after dry February, scientists warn

March 17, 2023 | fool.com

Regions Bank Review: A Great Place for All-in-One Banking

March 16, 2023 | usatoday.com

NCAA Tournament South Region breakdown: Alabama clearly the favorite but championship pedigree lurks

March 4, 2023 | bbc.co.uk

Welsh rugby crisis: Regions braced to lose star names amid budget cuts

March 4, 2023 | cbsnews.com

California drought update: Winter storm lifts regions out of drought

February 24, 2023 | skift.com

See What Regions of the World Are Fully Recovered: New Skift Travel Health Index

February 18, 2023 | cbsnews.com

Dog flu cases on the rise in some U.S. regions this winter season

February 14, 2023 | usnews.com

Ukraine Says Three Major Regions Can Avoid Power Cuts After Attacks

October 29, 2022 | reuters.com

RGIN.PK - Regenicin Inc | Stock Price & Latest News | Reuters

October 7, 2022 | reuters.com

Russia's Federation Council ratifies annexation of four Ukrainian regions

October 4, 2022 | reuters.com

Russian parliament to consider legal steps to absorb Ukrainian regions

September 25, 2022 | marketwatch.com

Ukraine regions largely under control of Moscow-aligned separatists vote in referendums on joining Russia

September 24, 2022 | theguardian.com

Four occupied Ukraine regions plan imminent ‘votes’ on joining Russia

August 30, 2022 | ca.finance.yahoo.com

The Global Tissue Engineered Skin Substitutes Market grew USD 1,784.48 million by 2027, at a CAGR of 12.23%.

February 11, 2022 | nasdaq.com

RGIN Pre-Market Quotes

See More Headlines

Receive RGIN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Regenicin and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/19/2020
Today: 4/20/2024
Fiscal Year End: 9/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: OTCMKTS:RGIN
CUSIP: N/A
CIK: 1412659
Web: www.regenicin.com
Phone: (732) 757-5500
Fax: N/A
Employees: 3
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.04) per share
Price / Book: -0.13

Miscellaneous

Outstanding Shares: 165,770,000
Free Float: N/A
Market Cap: $828,850.00
Optionable: Not Optionable
Beta: N/A

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. Randall E. McCoy (Age 75)
Chairman, CEO & President
Comp: $250k
Mr. John J. Weber (Age 74)
CFO & Director
Comp: $125k
Dr. J. Roy Nelson Ph.D. (Age 76)
Controller & Chief Science Officer
Comp: $150k

Key Competitors

View All Competitors

RGIN Stock Analysis - Frequently Asked Questions

How have RGIN shares performed in 2024?: Regenicin's stock was trading at $0.0001 at the beginning of 2024. Since then, RGIN shares have increased by 4,900.0% and is now trading at $0.0050.
View the best growth stocks for 2024 here.
How were Regenicin's earnings last quarter?: Regenicin, Inc. (OTCMKTS:RGIN) released its quarterly earnings results on Wednesday, August, 19th. The company reported $0.00 earnings per share (EPS) for the quarter.
What other stocks do shareholders of Regenicin own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Regenicin investors own include Energous (WATT), Vital Therapies (VTL), Xerox (XRX), Allergan (AGN), Leafbuyer Technologies (LBUY), (ZINCQ) (ZINCQ), Ambarella (AMBA) and Alstom (ALO).
How do I buy shares of Regenicin?: Shares of RGIN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:RGIN) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial